Is CONSORT a Risk of Bias Tool for Experimental Studies: A Big Misunderstanding
- PMID: 40391306
- PMCID: PMC12085767
- DOI: 10.34172/jcs.025.33575
Is CONSORT a Risk of Bias Tool for Experimental Studies: A Big Misunderstanding
Abstract
Introduction: In order to avoid bias in systematic reviews (SRs), the accuracy in selection of risk of bias (RoB) assessment tools is essential to obtain highest level of evidence for evidence-based decision making in health care. We aimed to review how 'CONSORT statement', as a reporting quality of randomized controlled trials, has been misused in recent SRs as a ROB tool.
Methods: A mini-review was performed in international databases including PubMed, Google Scholar and hand-searches for published and unpublished literature from 2000 to 2021 and written in English. The following keywords: risk of bias, "Consolidated Standards of Reporting Trials", CONSORT, "systematic review" were used. Citations were screened and those meeting our inclusion criteria were retained.
Results: A total of 11 SRs were identified that misused CONSORT as a ROB tool, four of which were used only CONSORT as ROB tool. Different authentic magazines from various countries were recognized.
Conclusion: The CONSORT statement aims to increase clarity and consistency of transparency of reporting in randomized controlled trials. It is quite essential to draw the attention of SR researchers, journal editors/reviewers as well as the reading audience to the fact that CONSORT statement CONSORT statement is not a ROB tool.
Keywords: CONSORT; Clinical trials; Epidemiologic methods; Quality of reporting; Systematic reviews.
© 2025 The Author(s).
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
A systematic review of orthopaedic manual therapy randomized clinical trials quality.J Man Manip Ther. 2016 Dec;24(5):241-252. doi: 10.1080/10669817.2015.1119372. J Man Manip Ther. 2016. PMID: 27956817 Free PMC article.
-
The effect of the CONSORT statement on the amount of "unclear" Risk of Bias reporting in Cochrane Systematic Reviews.PLoS One. 2020 Jul 10;15(7):e0235535. doi: 10.1371/journal.pone.0235535. eCollection 2020. PLoS One. 2020. PMID: 32650340 Free PMC article.
-
Quality of reporting and risk of bias: a review of randomised trials in occupational health.Occup Environ Med. 2021 Sep;78(9):691-696. doi: 10.1136/oemed-2020-107038. Epub 2021 Jun 23. Occup Environ Med. 2021. PMID: 34162718 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
References
-
- Jarde A, Losilla JM, Vives J. Methodological quality assessment tools of non-experimental studies: a systematic review. An Psicol. 2012;28(2):617–28. doi: 10.6018/analesps.28.2.148911. - DOI
-
- Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res 2020; 7(1): 7. what are they and which is better? Mil Med Res. 2020;7(1):what are they and which is better? Mil Med Res 2020; 7(1). doi: 10.1186/s40779-020-00238-8. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials